Experts called the most expensive acquired at the expense of budget drugs
Show original
Analysts of JOINT-STOCK COMPANY "GRUPPA DSM" designated the most expensive medicine acquired last year on state tenders, gennoterapevtichesky "Luksturna" — 26 million rubles for packing. The maximum volume of purchases — at "Spinraza" from muscular...
Analysis
×
Sergei Aleksandrovich Shulyak
Last position: Director general, JSC DSM Group (JOINT-STOCK COMPANY "GROUPA DSM")
Dmitry Borisovich Pogrebinsky
Last position: CEO (CLOSED JOINT-STOCK COMPANY CENTER FOR IMPLEMENTATION "PROTEK")
Geodakyan Artem
Stepanov Mikhail
PJSC ALROSA
160Main activity:Mining
Фонд "Круг добра"
4Organizations
JOINT-STOCK COMPANY "GROUPA DSM"
8Organizations